Bosutinib chronic myelogenous leukaemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Stylized skeletal form...

Bosutinib chronic myelogenous leukaemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Stylized skeletal form...
SuperStock offers millions of photos, videos, and stock assets to creatives around the world. This image of Bosutinib chronic myelogenous leukaemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Stylized skeletal form... by MOLEKUUL/SPL/Science Photo Library is available for licensing today.
Royalty Free License
Royalty-Free Standard Commercial licenses are granted for worldwide, non-exclusive and perpetual use, unless specifically noted otherwise. All Royalty-Free transactions are final. The Royalty-Free Standard Commercial license has no limitations and covers up to 15 users.
  • $50.00 Low500 X 315
  • $150.00 Med750 X 472
  • $250.00 High2100 X 1322
  • $350.00 Super High7451 X 4691
$1,225.00
RF High / Super Res 5 Pack
Save $525.00
$245.00
per download
Order a Framed Print
Looking for a license?
Click here, and we'll help you find it! Questions? Just ask!
DETAILS
Image Number: 4128R-13162867Royalty FreeCredit Line:MOLEKUUL/SPL/Science Photo Library/SuperStockCollection:Science Photo LibraryContributor:MOLEKUUL/SPLModel Release:NoProperty Release:NoResolution:7451×4691
ABL
artwork|
BCR|
bosutinib|
cancer|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|